Schizophrenia
Item
patients suffering from schizophrenia (dsm iv).
boolean
C0036341 (UMLS CUI [1])
Antipsychotic Agents Quantity failed | Intolerance to Antipsychotic Agents
Item
failure of at least one previous antipsychotic for intolerance.
boolean
C0040615 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0231175 (UMLS CUI [1,3])
C1744706 (UMLS CUI [2,1])
C0040615 (UMLS CUI [2,2])
Psychotic symptom Independent of Other medical condition | Psychotic symptom Independent of Substance Use Disorders
Item
psychotic symptoms that are not secondary to a general medical condition or substance abuse.
boolean
C0871189 (UMLS CUI [1,1])
C0332291 (UMLS CUI [1,2])
C3843040 (UMLS CUI [1,3])
C0871189 (UMLS CUI [2,1])
C0332291 (UMLS CUI [2,2])
C0038586 (UMLS CUI [2,3])
Age
Item
ages between 18-65 years old.
boolean
C0001779 (UMLS CUI [1])
Psychotropic Drugs Dose Stable | Antidepressive Agents | Mood Stabilizer | Sedatives | Hypnotics
Item
patients receiving other psychotropic medications (anti-depressants, mood stabilizers, sedatives, hypnotics) must be on a stable dose for at least 2 weeks before entering the trial.
boolean
C0033978 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
C0003289 (UMLS CUI [2])
C2917435 (UMLS CUI [3])
C0036557 (UMLS CUI [4])
C0020591 (UMLS CUI [5])
Informed Consent
Item
able to understand and sign an informed consent form.
boolean
C0021430 (UMLS CUI [1])
Psychotic Disorders caused by Medical condition
Item
patients suffering from psychotic disorders caused by a general medical condition.
boolean
C0033975 (UMLS CUI [1,1])
C0015127 (UMLS CUI [1,2])
C3843040 (UMLS CUI [1,3])
High suicide risk Depression scale Schizophrenia
Item
patients having high suicidal risk, as measured by score of 2 or more in cdss -
boolean
C1271074 (UMLS CUI [1,1])
C0679604 (UMLS CUI [1,2])
C0036341 (UMLS CUI [1,3])
Depression scale Schizophrenia
Item
calgary depression scale for schizophrenia.
boolean
C0679604 (UMLS CUI [1,1])
C0036341 (UMLS CUI [1,2])
Medical condition Unstable | Endocrine System Diseases | Nutrition Disorders | Liver diseases | Urologic Diseases
Item
patients suffering from an unstable clinically significant medical condition (endocrine, nutritional, hepatic, urinary).
boolean
C3843040 (UMLS CUI [1,1])
C0443343 (UMLS CUI [1,2])
C0014130 (UMLS CUI [2])
C3714509 (UMLS CUI [3])
C0023895 (UMLS CUI [4])
C0042075 (UMLS CUI [5])
Cardiovascular Disease | Prolonged QT interval | Gender
Item
significant cardiovascular illness, and/or qt prolongation at screening (more then 450 msec for male or 470 msec for female).
boolean
C0007222 (UMLS CUI [1])
C0151878 (UMLS CUI [2])
C0079399 (UMLS CUI [3])
Malignant Neoplasms | Neurodegenerative Disorders
Item
patients suffering from a malignancy or neuro-degenerative illness (e.g. parkinsons'
boolean
C0006826 (UMLS CUI [1])
C0524851 (UMLS CUI [2])
Parkinson Disease
Item
disease)
boolean
C0030567 (UMLS CUI [1])
Organic brain disorder | Epilepsy | Mental Retardation
Item
patients suffering from organic brain disorders, including epilepsy and mental retardation.
boolean
C4062280 (UMLS CUI [1])
C0014544 (UMLS CUI [2])
C0025362 (UMLS CUI [3])
Mood Disorders
Item
patients suffering from a clinically significant mood disorder.
boolean
C0525045 (UMLS CUI [1])
Pregnancy
Item
pregnancy.
boolean
C0032961 (UMLS CUI [1])
Substance Dependence
Item
history of drug or alcohol dependence within the last year.
boolean
C0038580 (UMLS CUI [1])
Risperidone Unresponsive to Treatment
Item
previous documented non-response to risperidone.
boolean
C0073393 (UMLS CUI [1,1])
C0205269 (UMLS CUI [1,2])
Pharmaceutical Preparations Contraindicated Sertindole | Pharmaceutical Preparations Contraindicated Risperidone
Item
patients using medicinal products that are contraindicated with sertindole and/or risperidone.
boolean
C0013227 (UMLS CUI [1,1])
C1444657 (UMLS CUI [1,2])
C0084528 (UMLS CUI [1,3])
C0013227 (UMLS CUI [2,1])
C1444657 (UMLS CUI [2,2])
C0073393 (UMLS CUI [2,3])